~~<i id='34FE064892'><strike id='34FE064892'><tt id='34FE064892'><pre id='34FE064892'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：explore 2025-09-30 17:03:24 - browse：81223

Editor’s note: A recording of the event is embedded below.

After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

Featured Speakers

Irena Melnikova, Ph.D., partner, Pfizer Ventures
Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： The system is set up to fail children with medical complexity

Wikipedia

leisure time

focus

explore

Wikipedia

explore

AFP/GettyImagesMostofthetime,it’seasytobeintheplacebogroup ofaclinicaltrial:nosideeffects,minimalann

WSS

Community Health Systems hospitals under DOJ investigation

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Dario to buy mental health app maker Twill in cash and stock deal

Pharma companies must ensure equitable access to obesity drugs

Why palliative psychiatry is worth discussing

Statins may not be needed by millions of people, study suggests

focus

comprehensive

Featured Speakers

Wikipedia

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Obesity drugs seen as possible treatment for liver disease MASH

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Why palliative psychiatry is worth discussing

Malaria cases in Florida and Texas: Here’s what you need to know

Teladoc has a new CEO, but challenges remain the same

BioMarin wins approval for gene therapy to treat hemophilia A

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

The high cost of giving birth even with insurance

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

leisure time

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

STAT readers on older presidents, polypills, Medicare, and more

Why palliative psychiatry is worth discussing

Pharma companies must ensure equitable access to obesity drugs

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Pharma companies must ensure equitable access to obesity drugs

focus

explore

Wikipedia

explore